Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study).
Saved in:
| Title: | Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study). |
|---|---|
| Authors: | Okai, Annette F.1 (AUTHOR) afokai@gmail.com, Amezcua, Lilyana2 (AUTHOR), Berkovich, Regina R.2,3 (AUTHOR), Chinea, Angel R.4 (AUTHOR), Edwards, Keith R.5 (AUTHOR), Steingo, Brian6 (AUTHOR), Walker, Aljoeson7 (AUTHOR), Jacobs, Alan K.8 (AUTHOR), Daizadeh, Nadia8 (AUTHOR), Williams, Mitzi J.9 (AUTHOR) |
| Source: | Neurology & Therapy. Dec2019, Vol. 8 Issue 2, p367-381. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
